世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
 Anatomic Pathology Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
The global anatomic pathology market is set to experience significant growth, expanding at a CAGR of 7.9% from 2025 to 2032. The market is forecast to grow from US$4.07 billion in 2025 to US$6.93 b... もっと見る
※当ページの内容はウェブ更新時の情報です。
SummaryThe global anatomic pathology market is set to experience significant growth, expanding at a CAGR of 7.9% from 2025 to 2032. The market is forecast to grow from US$4.07 billion in 2025 to US$6.93 billion by the end of 2032, driven by advancements in diagnostic technologies, increasing incidences of chronic diseases, and a rising aging population.Anatomic pathology is a vital branch of pathology focusing on the microscopic examination of tissues and cells for disease diagnosis. This discipline encompasses techniques such as histopathology, cytology, and immunohistochemistry to provide comprehensive insights into structural and functional tissue changes. Anatomic pathology plays a critical role in guiding treatment decisions, predicting patient outcomes, and advancing disease understanding. As technological advancements and demographic trends reshape healthcare, anatomic pathology remains integral to diagnostic and therapeutic strategies. Market Insights Key Growth Drivers: 1.Advancements in Diagnostic Technologies: oRapid innovations in imaging, molecular pathology, and automation have enhanced diagnostic precision and efficiency. oDigital pathology enables slide digitization, remote collaboration, and artificial intelligence (AI) integration for faster and more accurate diagnoses. 2.Rising Disease Prevalence: oIncreasing incidences of cancer and chronic diseases drive demand for accurate and timely pathology services. oThe aging population, more susceptible to various health conditions, further fuels market growth. Market Challenges: 1.Integration of Telepathology and Regulatory Compliance: oWhile telepathology offers remote diagnostics and collaboration, navigating diverse regulatory standards, especially regarding data privacy and diagnostic accuracy, remains a challenge. 2.Technological Integration Hurdles: oHigh costs, interoperability issues, and the need for staff training complicate the transition from traditional to digital pathology platforms. Business Opportunities Advanced Diagnostic Technologies: •The integration of digital pathology, AI, and molecular diagnostics enhances diagnostic accuracy and workflow efficiency. •AI-powered algorithms accelerate data interpretation, providing valuable insights and reducing turnaround times. Collaborative Research Initiatives: •Partnerships between pathology laboratories, research institutions, and pharmaceutical companies foster innovation in diagnostic methodologies. •Joint efforts in biomarker discovery and companion diagnostics contribute to personalized medicine advancements. Regional Analysis North America: •Maintains dominance due to a robust healthcare system, high disease awareness, and significant investments in diagnostic technologies. •Over the past three years, the U.S. has experienced a 24.3% increase in the adoption of advanced pathology services, driving market growth. Europe: •A leader in the adoption of cutting-edge diagnostic technologies, supported by collaborative research initiatives. •Countries like the UK prioritize sustainability and standardized pathology practices, positioning Europe as a key player in the global market. South Asia & Pacific: •Emerging as the fastest-growing region due to rapid healthcare infrastructure development and an increasing disease burden. •Rising awareness of preventive healthcare measures boosts demand for pathology services. Latin America and Middle East & Africa: •These regions are witnessing steady growth driven by improved access to healthcare and diagnostic services. Competitive Analysis Key Market Players: •Laboratory Corporation of America Holdings •Quest Diagnostics Incorporated •Sakura Finetek USA, Inc. •F. Hoffmann-La Roche AG •Cardinal Health, Inc. •BioGenex •NeoGenomics •Bio SB •Agilent Technologies Market Segmentation By Product and Service: •Anatomic Pathology Instruments •Anatomic Pathology Consumables •Anatomic Pathology Services By Application: •Disease Diagnosis •Drug Discovery and Development •Others By End-use: •Hospitals •Research Laboratories •Diagnostic Laboratories •Others By Region: •North America •Europe •Asia Pacific •Latin America •Middle East & Africa Table of Contents1. Executive Summary1.1. Global Anatomic Pathology Market Snapshot 1.2. Future Projections 1.3. Key Market Trends 1.4. Regional Snapshot, by Value, 2025 1.5. Analyst Recommendations 2. Market Overview 2.1. Market Definitions and Segmentations 2.2. Market Dynamics 2.2.1. Drivers 2.2.2. Restraints 2.2.3. Market Opportunities 2.3. Value Chain Analysis 2.4. Porter’s Five Forces Analysis 2.5. COVID-19 Impact Analysis 2.5.1. Supply 2.5.2. Demand 2.6. Impact of Ukraine-Russia Conflict 2.7. Economic Overview 2.7.1. World Economic Projections 2.8. PESTLE Analysis 3. Global Anatomic Pathology Market Outlook, 2019 – 2032 3.1. Global Anatomic Pathology Market Outlook, by Product and Service, Value (US$ Bn), 2019 – 2032 3.1.1. Key Highlights 3.1.1.1. Anatomic Pathology Instruments 3.1.1.2. Anatomic Pathology Consumables 3.1.1.3. Anatomic Pathology Services 3.2. Global Anatomic Pathology Market Outlook, by Application, Value (US$ Bn), 2019 – 2032 3.2.1. Key Highlights 3.2.1.1. Disease Diagnosis 3.2.1.2. Drug Discovery and Development 3.2.1.3. Others 3.3. Global Anatomic Pathology Market Outlook, by End-use, Value (US$ Bn), 2019 – 2032 3.3.1. Key Highlights 3.3.1.1. Hospitals 3.3.1.2. Research Laboratories 3.3.1.3. Diagnostic Laboratories 3.3.1.4. Others 3.4. Global Anatomic Pathology Market Outlook, by Region, Value (US$ Bn), 2019 – 2032 3.4.1. Key Highlights 3.4.1.1. North America 3.4.1.2. Europe 3.4.1.3. Asia Pacific 3.4.1.4. Latin America 3.4.1.5. Middle East & Africa 4. North America Anatomic Pathology Market Outlook, 2019 – 2032 4.1. North America Anatomic Pathology Market Outlook, by Product and Service, Value (US$ Bn), 2019 – 2032 4.1.1. Key Highlights 4.1.1.1. Anatomic Pathology Instruments 4.1.1.2. Anatomic Pathology Consumables 4.1.1.3. Anatomic Pathology Services 4.2. North America Anatomic Pathology Market Outlook, by Application, Value (US$ Bn), 2019 – 2032 4.2.1. Key Highlights 4.2.1.1. Disease Diagnosis 4.2.1.2. Drug Discovery and Development 4.2.1.3. Others 4.3. North America Anatomic Pathology Market Outlook, by End-use, Value (US$ Bn), 2019 – 2032 4.3.1. Key Highlights 4.3.1.1. Hospitals 4.3.1.2. Research Laboratories 4.3.1.3. Diagnostic Laboratories 4.3.1.4. Others 4.4. North America Anatomic Pathology Market Outlook, by Country, Value (US$ Bn), 2019 – 2032 4.4.1. Key Highlights 4.4.1.1. Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 – 2032 4.4.1.2. Anatomic Pathology Market by Application, Value (US$ Bn), 2019 – 2032 4.4.1.3. Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 – 2032 4.4.1.4. Canada Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 – 2032 4.4.1.5. Canada Anatomic Pathology Market by Application, Value (US$ Bn), 2019 – 2032 4.4.1.6. Canada Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 – 2032 4.4.2. BPS Analysis/Market Attractiveness Analysis 5. Europe Anatomic Pathology Market Outlook, 2019 – 2032 5.1. Europe Anatomic Pathology Market Outlook, by Product and Service, Value (US$ Bn), 2019 – 2032 5.1.1. Key Highlights 5.1.1.1. Anatomic Pathology Instruments 5.1.1.2. Anatomic Pathology Consumables 5.1.1.3. Anatomic Pathology Services 5.2. Europe Anatomic Pathology Market Outlook, by Application, Value (US$ Bn), 2019 – 2032 5.2.1. Key Highlights 5.2.1.1. Disease Diagnosis 5.2.1.2. Drug Discovery and Development 5.2.1.3. Others 5.3. Europe Anatomic Pathology Market Outlook, by End-use, Value (US$ Bn), 2019 – 2032 5.3.1. Key Highlights 5.3.1.1. Hospitals 5.3.1.2. Research Laboratories 5.3.1.3. Diagnostic Laboratories 5.3.1.4. Others 5.4. Europe Anatomic Pathology Market Outlook, by Country, Value (US$ Bn), 2019 – 2032 5.4.1. Key Highlights 5.4.1.1. Germany Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 – 2032 5.4.1.2. Germany Anatomic Pathology Market by Application, Value (US$ Bn), 2019 – 2032 5.4.1.3. Germany Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 – 2032 5.4.1.4. U.K. Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 – 2032 5.4.1.5. U.K. Anatomic Pathology Market by Application, Value (US$ Bn), 2019 – 2032 5.4.1.6. U.K. Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 – 2032 5.4.1.7. France Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 – 2032 5.4.1.8. France Anatomic Pathology Market by Application, Value (US$ Bn), 2019 – 2032 5.4.1.9. France Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 – 2032 5.4.1.10. Italy Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 – 2032 5.4.1.11. Italy Anatomic Pathology Market by Application, Value (US$ Bn), 2019 – 2032 5.4.1.12. Italy Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 – 2032 5.4.1.13. Turkey Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 – 2032 5.4.1.14. Turkey Anatomic Pathology Market by Application, Value (US$ Bn), 2019 – 2032 5.4.1.15. Turkey Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 – 2032 5.4.1.16. Russia Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 – 2032 5.4.1.17. Russia Anatomic Pathology Market by Application, Value (US$ Bn), 2019 – 2032 5.4.1.18. Russia Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 – 2032 5.4.1.19. Rest of Europe Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 – 2032 5.4.1.20. Rest of Europe Anatomic Pathology Market by Application, Value (US$ Bn), 2019 – 2032 5.4.1.21. Rest of Europe Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 – 2032 5.4.2. BPS Analysis/Market Attractiveness Analysis 6. Asia Pacific Anatomic Pathology Market Outlook, 2019 – 2032 6.1. Asia Pacific Anatomic Pathology Market Outlook, by Product and Service, Value (US$ Bn), 2019 – 2032 6.1.1. Key Highlights 6.1.1.1. Anatomic Pathology Instruments 6.1.1.2. Anatomic Pathology Consumables 6.1.1.3. Anatomic Pathology Services 6.2. Asia Pacific Anatomic Pathology Market Outlook, by Application, Value (US$ Bn), 2019 – 2032 6.2.1. Key Highlights 6.2.1.1. Disease Diagnosis 6.2.1.2. Drug Discovery and Development 6.2.1.3. Others 6.3. Asia Pacific Anatomic Pathology Market Outlook, by End-use, Value (US$ Bn), 2019 – 2032 6.3.1. Key Highlights 6.3.1.1. Hospitals 6.3.1.2. Research Laboratories 6.3.1.3. Diagnostic Laboratories 6.3.1.4. Others 6.4. Asia Pacific Anatomic Pathology Market Outlook, by Country, Value (US$ Bn), 2019 – 2032 6.4.1. Key Highlights 6.4.1.1. China Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 – 2032 6.4.1.2. China Anatomic Pathology Market by Application, Value (US$ Bn), 2019 – 2032 6.4.1.3. China Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 – 2032 6.4.1.4. Japan Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 – 2032 6.4.1.5. Japan Anatomic Pathology Market by Application, Value (US$ Bn), 2019 – 2032 6.4.1.6. Japan Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 – 2032 6.4.1.7. South Korea Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 – 2032 6.4.1.8. South Korea Anatomic Pathology Market by Application, Value (US$ Bn), 2019 – 2032 6.4.1.9. South Korea Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 – 2032 6.4.1.10. India Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 – 2032 6.4.1.11. India Anatomic Pathology Market by Application, Value (US$ Bn), 2019 – 2032 6.4.1.12. India Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 – 2032 6.4.1.13. Southeast Asia Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 – 2032 6.4.1.14. Southeast Asia Anatomic Pathology Market by Application, Value (US$ Bn), 2019 – 2032 6.4.1.15. Southeast Asia Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 – 2032 6.4.1.16. Rest of Asia Pacific Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 – 2032 6.4.1.17. Rest of Asia Pacific Anatomic Pathology Market by Application, Value (US$ Bn), 2019 – 2032 6.4.1.18. Rest of Asia Pacific Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 – 2032 6.4.2. BPS Analysis/Market Attractiveness Analysis 7. Latin America Anatomic Pathology Market Outlook, 2019 – 2032 7.1. Latin America Anatomic Pathology Market Outlook, by Product and Service, Value (US$ Bn), 2019 – 2032 7.1.1. Key Highlights 7.1.1.1. Anatomic Pathology Instruments 7.1.1.2. Anatomic Pathology Consumables 7.1.1.3. Anatomic Pathology Services 7.2. Latin America Anatomic Pathology Market Outlook, by Application, Value (US$ Bn), 2019 – 2032 7.2.1. Key Highlights 7.2.1.1. Disease Diagnosis 7.2.1.2. Drug Discovery and Development 7.2.1.3. Others 7.3. Latin America Anatomic Pathology Market Outlook, by End-use, Value (US$ Bn), 2019 – 2032 7.3.1. Key Highlights 7.3.1.1. Hospitals 7.3.1.2. Research Laboratories 7.3.1.3. Diagnostic Laboratories 7.3.1.4. Others 7.4. Latin America Anatomic Pathology Market Outlook, by Country, Value (US$ Bn), 2019 – 2032 7.4.1. Key Highlights 7.4.1.1. Brazil Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 – 2032 7.4.1.2. Brazil Anatomic Pathology Market by Application, Value (US$ Bn), 2019 – 2032 7.4.1.3. Brazil Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 – 2032 7.4.1.4. Mexico Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 – 2032 7.4.1.5. Mexico Anatomic Pathology Market by Application, Value (US$ Bn), 2019 – 2032 7.4.1.6. Mexico Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 – 2032 7.4.1.7. Argentina Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 – 2032 7.4.1.8. Argentina Anatomic Pathology Market by Application, Value (US$ Bn), 2019 – 2032 7.4.1.9. Argentina Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 – 2032 7.4.1.10. Rest of Latin America Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 – 2032 7.4.1.11. Rest of Latin America Anatomic Pathology Market by Application, Value (US$ Bn), 2019 – 2032 7.4.1.12. Rest of Latin America Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 – 2032 7.4.2. BPS Analysis/Market Attractiveness Analysis 8. Middle East & Africa Anatomic Pathology Market Outlook, 2019 – 2032 8.1. Middle East & Africa Anatomic Pathology Market Outlook, by Product and Service, Value (US$ Bn), 2019 – 2032 8.1.1. Key Highlights 8.1.1.1. Anatomic Pathology Instruments 8.1.1.2. Anatomic Pathology Consumables 8.1.1.3. Anatomic Pathology Services 8.2. Middle East & Africa Anatomic Pathology Market Outlook, by Application, Value (US$ Bn), 2019 – 2032 8.2.1. Key Highlights 8.2.1.1. Disease Diagnosis 8.2.1.2. Drug Discovery and Development 8.2.1.3. Others 8.3. Middle East & Africa Anatomic Pathology Market Outlook, by End-use, Value (US$ Bn), 2019 – 2032 8.3.1. Key Highlights 8.3.1.1. Hospitals 8.3.1.2. Research Laboratories 8.3.1.3. Diagnostic Laboratories 8.3.1.4. Others 8.4. Middle East & Africa Anatomic Pathology Market Outlook, by Country, Value (US$ Bn), 2019 – 2032 8.4.1. Key Highlights 8.4.1.1. GCC Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 – 2032 8.4.1.2. GCC Anatomic Pathology Market by Application, Value (US$ Bn), 2019 – 2032 8.4.1.3. GCC Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 – 2032 8.4.1.4. South Africa Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 – 2032 8.4.1.5. South Africa Anatomic Pathology Market by Application, Value (US$ Bn), 2019 – 2032 8.4.1.6. South Africa Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 – 2032 8.4.1.7. Egypt Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 – 2032 8.4.1.8. Egypt Anatomic Pathology Market by Application, Value (US$ Bn), 2019 – 2032 8.4.1.9. Egypt Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 – 2032 8.4.1.10. Nigeria Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 – 2032 8.4.1.11. Nigeria Anatomic Pathology Market by Application, Value (US$ Bn), 2019 – 2032 8.4.1.12. Nigeria Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 – 2032 8.4.1.13. Rest of Middle East & Africa Anatomic Pathology Market by Product and Service, Value (US$ Bn), 2019 – 2032 8.4.1.14. Rest of Middle East & Africa Anatomic Pathology Market by Application, Value (US$ Bn), 2019 – 2032 8.4.1.15. Rest of Middle East & Africa Anatomic Pathology Market by End-use, Value (US$ Bn), 2019 – 2032 8.4.2. BPS Analysis/Market Attractiveness Analysis 9. Competitive Landscape 9.1. Company Market Share Analysis, 2025 9.2. Competitive Dashboard 9.3. Company Profiles 9.3.1. BioGenex 9.3.1.1. Company Overview 9.3.1.2. Product and Service Portfolio 9.3.1.3. Financial Overview 9.3.1.4. Business Strategies and Development 9.3.2. Cardinal Health, Inc. 9.3.2.1. Company Overview 9.3.2.2. Product and Service Portfolio 9.3.2.3. Financial Overview 9.3.2.4. Business Strategies and Development 9.3.3. Sakura Finetek USA, Inc. 9.3.3.1. Company Overview 9.3.3.2. Product and Service Portfolio 9.3.3.3. Financial Overview 9.3.3.4. Business Strategies and Development 9.3.4. Quest Diagnostics Incorporated 9.3.4.1. Company Overview 9.3.4.2. Product and Service Portfolio 9.3.4.3. Financial Overview 9.3.4.4. Business Strategies and Development 9.3.5. Agilent Technologies 9.3.5.1. Company Overview 9.3.5.2. Product and Service Portfolio 9.3.5.3. Financial Overview 9.3.5.4. Business Strategies and Development 9.3.6. Bio SB 9.3.6.1. Company Overview 9.3.6.2. Product and Service Portfolio 9.3.6.3. Financial Overview 9.3.6.4. Business Strategies and Development 9.3.7. F. Hoffmann-La Roche AG 9.3.7.1. Company Overview 9.3.7.2. Product and Service Portfolio 9.3.7.3. Financial Overview 9.3.7.4. Business Strategies and Development 9.3.8. NeoGenomics 9.3.8.1. Company Overview 9.3.8.2. Product and Service Portfolio 9.3.8.3. Financial Overview 9.3.8.4. Business Strategies and Development 9.3.9. Laboratory Corporation of America Holdings 9.3.9.1. Company Overview 9.3.9.2. Product and Service Portfolio 9.3.9.3. Financial Overview 9.3.9.4. Business Strategies and Development 10. Appendix 10.1. Research Methodology 10.2. Report Assumptions 10.3. Acronyms and Abbreviations
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医療IT）の最新刊レポート
Fairfield Market Research社のヘルスケアIT分野での最新刊レポート
本レポートと同じKEY WORD（industry）の最新刊レポート
よくあるご質問Fairfield Market Research社はどのような調査会社ですか?Fairfield Market Researchでは、最新かつ最も関連性の高い市場データと洞察に満ちた詳細なレポートを発行しています。広範囲にわたり、業界動向や市場ベースのデータを含んでおり、顧客が... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
